RegCell is a novel therapeutics company.
RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 4, 2017 | Series Unknown | ¥20.26M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Chuo Shinkin Venture Capital | — | Series Unknown |